Tag: Rotech Healthcare
Rotech excited about CPAP alternative
December 20, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare recently partnered with Signifier Medical Technologies to offer the eXciteOSA device as an alternative option for OSA, part of the provider’s commitment to serving all patients, says CEO Robin Menchen.
The eXciteOSA device allows daytime treatment for approximately 20 minutes twice a day for the initial treatment period, which is ideal for those patients who cannot tolerate CPAP treatment when trying to sleep, she said.
“Our...
In brief: Rotech agreement, Merits USA president, Belluscura financing
November 27, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare has announced a supplier agreement with Signifier Medical Technologies to introduce the eXciteOSA device to payers, health care providers and patients to treat mild to moderate obstructive sleep apnea.
The eXciteOSA device, approved by the U.S. Food and Drug Administration, uses neuromuscular electrical stimulation to tone tongue muscles to maintain an open airway during sleep, improving sleep quality and overall health.
“Partnering...
Rotech to supply CPAP alternative
November 26, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare has announced a supplier agreement with Signifier Medical Technologies to introduce the eXciteOSA device to payers, health care providers and patients to treat mild to moderate obstructive sleep apnea.
The eXciteOSA device, approved by the U.S. Food and Drug Administration, uses neuromuscular electrical stimulation to tone tongue muscles to maintain an open airway during sleep, improving sleep quality and overall health.
“Partnering...
In brief: Owens & Minor’s FTC request, CVS Health’s exit, Medically Home’s leadership
October 16, 2024HME News Staff
RICHMOND, Va. – Owens & Minor and Rotech Healthcare on Oct. 11 each received a request for additional information and documentary materials from the Federal Trade Commission in connection with its review of the merger of the two companies.
The effect of a second request is to extend the waiting period imposed by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, until 30 days after each of the companies has substantially complied with the second request issued to...
Owens & Minor, Rotech receive second request from FTC
October 15, 2024HME News Staff
RICHMOND, Va. – Owens & Minor and Rotech Healthcare on Oct. 11 each received a request for additional information and documentary materials from the Federal Trade Commission in connection with its review of the merger of the two companies.
The effect of a second request is to extend the waiting period imposed by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, until 30 days after each of the companies has substantially complied with the second request issued to...
Analysts reflect on OMI deal, market conditions
September 13, 2024Theresa Flaherty, Managing Editor
Owens & Minor’s acquisition: Owens & Minor (OMI) acquired Rotech Healthcare for $1.36 billion, aiming to secure large payer contracts for value-based care and a capitated risk model.
Market impact: The acquisition, along with favorable conditions like improving interest rates and demand, could stimulate further M&A activity in the HME industry.
Quipt Home Medical’s strategy: Following the OMI-Rotech deal, Quipt Home Medical is focusing on acquiring companies...
Owens & Minor: ‘We’re only getting started’
August 6, 2024Theresa Flaherty, Managing Editor
RICHMOND, Va. – Owens & Minor’s Patient Direct segment is experiencing “considerable tailwinds” driven by the large numbers of U.S. adults suffering from chronic health conditions, company execs say.
In particular, the company continues to see growth in diabetes and sleep therapy, despite the “groundswell of support” for GLP-1 weight loss drugs, CEO Edward Pesicka told investors on a recent call to discuss the company’s second quarter 2024 earnings.
“We’re...
Owens & Minor to buy Rotech
July 23, 2024HME News Staff
RICHMOND, Va. - Owens & Minor has entered into a definitive agreement to buy Rotech Healthcare for $1.36 billion in cash.
Given the anticipated tax benefits from the transaction of about $40 million, the net purchase price is about $1.32 billion, representing 6.3x multiple of LTM EBITDA, excluding synergies.
"Rotech squarely fits into our existing Patient Direct segment and directly aligns with the strategy we outlined last December during our Investor Day, supporting our expansion...
In brief: Rotech’s notification, DOJ’s fraud record, VGM’s CISO
February 28, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare on Feb. 23 provided notification of a recent privacy incident experienced by Philips Respironics that may have impacted certain information of patients who purchased Philips sleep and respiratory devices from Rotech.
“Although Rotech is unaware of any misuse of information resulting from this event, we are providing this notice in an abundance of caution,” the company stated on its website.
When reached for comment, a spokesman...
Rotech provides notification of Philips breach
February 26, 2024HME News Staff
ORLANDO, Fla. – Rotech Healthcare on Feb. 23 provided notification of a recent privacy incident experienced by Philips Respironics that may have impacted certain information of patients who purchased Philips sleep and respiratory devices from Rotech.
“Although Rotech is unaware of any misuse of information resulting from this event, we are providing this notice in an abundance of caution,” the company stated on its website.
When reached for comment, a spokesman...